Altre lingue BioHarvest Sciences Inc. Deutsche Boerse AG

Azioni

8MV0

CA09076J2074

Tempo differito Deutsche Boerse AG Altri mercati azionari 08:12:33 03/07/2024			Variaz. 5gg	Var. 1 gen.
5,46 ^EUR	+0,55%		-3,36%	+12,23%

28/06	BioHarvest Sciences raccoglie 4,3 milioni di dollari nella prima tranche di finanziamento e segnala la conversione delle note di debito	MT
30/05	BioHarvest Sciences Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioHarvest Sciences Raises US$4.3 Million in First Tranche of Financing, Reports Debt Notes Conversion	28/06
BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes	28/06
BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024	24/06
BIOHARVEST SCIENCES ANNOUNCES A PRIVATE PLACEMENT OF UP TO USD $5 MILLION AND CONVERSION OF DEBT NOTES	24/06
BioHarvest Sciences Announces US$5 Million Private-Placement Financing, Conversion of Debt Notes	21/06
BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes	21/06
BioHarvest Sciences Inc. announced that it expects to receive CAD 6.847977 million in funding	21/06
BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024	12/06
BioHarvest Sciences Hits Major Sales Milestone with VINIA seeing sales records	06/06
BioHarvest Sciences Announces Record $2 Million Monthly Sales	06/06
BioHarvest Sciences Reports Robust Q1 2024 Financial Growth and Strategic Expansion Plans	31/05
BioHarvest Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/05
BioHarvest Sciences Reports First Quarter 2024 Financial Results	30/05
BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time	01/05
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
BioHarvest Sciences Inc. Provides Revenue Guidance for the First Quarter and Second Quarter of 2024	30/04
BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing	30/04
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results	30/04
BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioHarvest Sciences Inc. Deutsche Boerse AG

Azioni

8MV0

CA09076J2074

Altre lingue

Filtri